in 3 studies for adult acute myelogenous leukemia ( aml ) treated with bhac-dmp , bhac-dmp ( ii ) and m-85 from 1979 to 1987 , intensive induction resulted in a higher cure rate , since reduction of the blasts in bone marrow at 2 weeks after the initiation of therapy to less than 20 % was the most significant prognostic factor to predict the long complete remission ( cr ) , followed by initial wbc counts ( less than 60,000/cmm ) and achievement of cr within 50 days or by one course of induction therapy .
C0220615
adult acute myelogenous leukemia
C0005953
bone marrow